NL188157C - Werkwijze voor de bereiding van o-gealkyleerde hydroxylaminen, werkwijze ter bereiding van een geneesmiddel daaruit en gevormd geneesmiddel. - Google Patents

Werkwijze voor de bereiding van o-gealkyleerde hydroxylaminen, werkwijze ter bereiding van een geneesmiddel daaruit en gevormd geneesmiddel.

Info

Publication number
NL188157C
NL188157C NLAANVRAGE7712291,A NL7712291A NL188157C NL 188157 C NL188157 C NL 188157C NL 7712291 A NL7712291 A NL 7712291A NL 188157 C NL188157 C NL 188157C
Authority
NL
Netherlands
Prior art keywords
medicinal product
hydroxylamins
alkylated
preparing
preparation
Prior art date
Application number
NLAANVRAGE7712291,A
Other languages
English (en)
Dutch (nl)
Other versions
NL7712291A (nl
NL188157B (nl
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NL7712291A publication Critical patent/NL7712291A/xx
Publication of NL188157B publication Critical patent/NL188157B/xx
Application granted granted Critical
Publication of NL188157C publication Critical patent/NL188157C/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/06Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with radicals, containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NLAANVRAGE7712291,A 1976-11-09 1977-11-08 Werkwijze voor de bereiding van o-gealkyleerde hydroxylaminen, werkwijze ter bereiding van een geneesmiddel daaruit en gevormd geneesmiddel. NL188157C (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762651083 DE2651083A1 (de) 1976-11-09 1976-11-09 Neue o-alkylierte hydroxylamine, verfahren zu ihrer herstellung und ihre verwendung

Publications (3)

Publication Number Publication Date
NL7712291A NL7712291A (nl) 1978-05-11
NL188157B NL188157B (nl) 1991-11-18
NL188157C true NL188157C (nl) 1992-04-16

Family

ID=5992722

Family Applications (1)

Application Number Title Priority Date Filing Date
NLAANVRAGE7712291,A NL188157C (nl) 1976-11-09 1977-11-08 Werkwijze voor de bereiding van o-gealkyleerde hydroxylaminen, werkwijze ter bereiding van een geneesmiddel daaruit en gevormd geneesmiddel.

Country Status (18)

Country Link
US (1) US4404384A (fi)
JP (1) JPS5817454B2 (fi)
AT (1) AT363452B (fi)
AU (1) AU520996B2 (fi)
BE (1) BE860614A (fi)
CA (1) CA1081242A (fi)
CH (1) CH641757A5 (fi)
DE (1) DE2651083A1 (fi)
DK (1) DK496977A (fi)
ES (1) ES463803A1 (fi)
FI (1) FI773353A (fi)
FR (1) FR2370028A1 (fi)
GB (1) GB1540028A (fi)
HU (1) HU176533B (fi)
IL (1) IL53337A0 (fi)
NL (1) NL188157C (fi)
SE (1) SE441265B (fi)
ZA (1) ZA776670B (fi)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2651083A1 (de) * 1976-11-09 1978-05-18 Hoechst Ag Neue o-alkylierte hydroxylamine, verfahren zu ihrer herstellung und ihre verwendung
EP0369944A1 (de) * 1988-11-18 1990-05-23 Ciba-Geigy Ag Substituierte Oxadiaminobutane
US4965390A (en) * 1990-02-02 1990-10-23 Ciba-Geigy Corporation Hydroxamic acid esters
US5075504A (en) * 1990-02-02 1991-12-24 Ciba-Geigy Corporation Process for the preparation of O-substituted hydroxylamines
IL97759A0 (en) * 1990-04-11 1992-06-21 Ciba Geigy Ag Hydroxylamine compounds
HU207290B (en) * 1990-06-13 1993-03-29 Sandoz Ag Process for producing hydroxamic acid derivatives and pharmaceutical compositions containing them
EP0495750A3 (en) * 1991-01-14 1992-09-16 Ciba-Geigy Ag Heterocyclic hydroxylamine
DE4244390A1 (de) * 1992-12-29 1994-06-30 Basf Ag Verfahren zur Herstellung von Oximino-Derivaten und neue Oximino-Derivate
HU218480B (hu) * 1995-06-15 2000-09-28 BIOREX Kutató és Fejlesztő Rt. Hidroxilaminszármazékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények
HU222994B1 (hu) 1995-11-02 2004-01-28 BIOREX Kutató és Fejlesztő Rt. Hidroxilaminszármazékok és azok alkalmazása sejtek molekuláris chaperon-termelésének fokozására alkalmas gyógyszerkészítmények előállítására
WO2003057664A1 (en) 2002-01-11 2003-07-17 Biorex Kutató És Fejlesztö Rt. Carboxamidine derivatives and their use in the treatment of vascular diseases
HUP0303584A3 (en) 2003-10-30 2009-12-28 Cytrx Corp Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseases
DE102005044108A1 (de) 2005-09-15 2007-03-29 Bayer Cropscience Ag Dioxazin- und Oxdiazin-substituierte Arylamide
TW200831479A (en) * 2006-09-26 2008-08-01 Cytrx Corp Pharmaceutical compositions and methods for treating diseases
KR20140121469A (ko) * 2012-02-03 2014-10-15 노파르티스 아게 N-(4-시클로헥실-3-트리플루오로메틸-벤질옥시)-아세트이미드산 에틸 에스테르의 제조 방법
MX2023005954A (es) 2020-11-19 2023-09-04 Zevra Denmark As Procesos para preparar citrato de arimoclomol e intermediarios del mismo.

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1149364B (de) * 1960-07-05 1963-05-30 Bayer Ag Verfahren zur Herstellung von O-(Alkylamino)-hydroxylaminen
GB1017601A (en) * 1961-02-22 1966-01-19 Lepetit Spa O-(ª‰-hydroxyethyl)-hydroxylamine and derivatives thereof
US3262978A (en) * 1963-06-19 1966-07-26 Colgate Palmolive Co O-arylamino-and-aralkyl-amino-alkylhydroxyl-amines
US3342678A (en) * 1964-02-10 1967-09-19 Carter Wallace Lowering blood cholesterol levels in warm-blooded animals with phenoxyethoxy or phenoxy-propoxy amine derivatives
HU162578B (fi) * 1971-02-15 1973-03-28
CA1012540A (en) * 1972-06-17 1977-06-21 Sumitomo Chemical Company 2-propanol derivatives and preparation thereof
DE2651084A1 (de) * 1976-11-09 1978-12-14 Hoechst Ag Basisch substituirte o-(2-hydroxypropyl) -aldoxime, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE2651083A1 (de) * 1976-11-09 1978-05-18 Hoechst Ag Neue o-alkylierte hydroxylamine, verfahren zu ihrer herstellung und ihre verwendung
DE2658762A1 (de) * 1976-12-24 1978-06-29 Hoechst Ag Neue o-alkylierte oxime, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE2820013A1 (de) * 1978-05-08 1979-11-22 Hoechst Ag Verfahren zur herstellung von o-alkylierten hydroxylaminen

Also Published As

Publication number Publication date
ES463803A1 (es) 1978-06-16
JPS5368711A (en) 1978-06-19
FI773353A (fi) 1978-05-10
GB1540028A (en) 1979-02-07
NL7712291A (nl) 1978-05-11
HU176533B (en) 1981-03-28
CH641757A5 (en) 1984-03-15
FR2370028A1 (fr) 1978-06-02
DE2651083A1 (de) 1978-05-18
SE7712630L (sv) 1978-05-10
BE860614A (fr) 1978-05-08
AU3043377A (en) 1979-05-17
JPS5817454B2 (ja) 1983-04-07
SE441265B (sv) 1985-09-23
US4404384A (en) 1983-09-13
ATA794477A (de) 1981-01-15
DE2651083C2 (fi) 1988-08-04
IL53337A0 (en) 1978-01-31
ZA776670B (en) 1978-08-30
AU520996B2 (en) 1982-03-11
NL188157B (nl) 1991-11-18
CA1081242A (en) 1980-07-08
AT363452B (de) 1981-08-10
DK496977A (da) 1978-05-10
FR2370028B1 (fi) 1980-06-20

Similar Documents

Publication Publication Date Title
NL7611015A (nl) Werkwijze voor de bereiding van een voedings- produkt, alsmede gevormde voortbrengselen die deze produkten bevatten.
NL7903421A (nl) N-gesubstitueerde moranolinederivaten, werkwijze voor de bereiding van een geneesmiddel daaruit en aldus verkregen geneesmiddel.
NL7701739A (nl) Werkwijze voor de bereiding van een polymeer.
NL7713618A (nl) Werkwijze voor de bereiding van een cosmetisch preparaat.
NL188157C (nl) Werkwijze voor de bereiding van o-gealkyleerde hydroxylaminen, werkwijze ter bereiding van een geneesmiddel daaruit en gevormd geneesmiddel.
NL7614567A (nl) Werkwijze ter bereiding van een geneesmiddel en werkwijze ter bereiding van de geneeskrachtige verbinding.
NL167436C (nl) Werkwijze voor de bereiding van 7beta-acylamino- -7alfa-alkoxycefalosporinen en 6beta-acylamino- -6alfa- alkoxypenicillinen, alsmede gevormd genees- middel.
NL7707785A (nl) Werkwijze voor de bereiding van n-gesubstitu- eerde chinazolinen met antihypertensieve wer- king, werkwijze voor de bereiding van een ge- neesmiddel met een dergelijke werking en ge- vormd geneesmiddel.
NL182476C (nl) Werkwijze voor de bereiding van een 4-halogeen-beta-pyron.
NL7704760A (nl) Werkwijze voor de bereiding van 4-aminopiperi- dinen, werkwijze voor de bereiding van een ge- neesmiddel met antihypertensieve werking en een dergelijk geneesmiddel.
NL7703237A (nl) Werkwijze voor de bereiding van een veterinair geneesmiddel.
NL7801251A (nl) Werkwijze voor de bereiding van farmacologisch werkzame chinolinen, werkwijze voor de berei- ding van een geneesmiddel en dergelijk genees- middel.
NL7613206A (nl) Werkwijze voor het bereiden van een geneesmiddel.
NL7708162A (nl) Werkwijze voor de bereiding van een farmaceu- tisch preparaat.
NL7712996A (nl) Werkwijze voor de bereiding van een farmaceu- tisch preparaat.
NL167981B (nl) Werkwijze voor de bereiding van een harspreparaat, als- mede hieruit verkregen gevormd voortbrengsel.
NL7705727A (nl) Werkwijze voor de bereiding van aryltrifluor- ethylaminen met hypotensieve werking, werkwijze voor de bereiding van een geneesmiddel met een dergelijke werking en gevormd geneesmiddel.
NL7703236A (nl) Werkwijze voor de bereiding van een veterinair geneesmiddel.
NL7614190A (nl) Werkwijze voor de bereiding van een farmaceutisch preparaat.
NL7700424A (nl) Werkwijze voor de bereiding van een farmaceu- tisch preparaat.
NL7604502A (nl) Werkwijze voor de bereiding van een geneesmiddel met anti-iflammatore werking, een geneesmiddel met een dergelijke werking en een werkwijze voor de bereiding van de werkzame verbindingen.
NL7710626A (nl) Werkwijze voor de bereiding van nieuwe rifamyci- neverbindingen, alsmede werkwijze voor de berei- ding van een geneesmiddel onder toepassing daar- van en gevormd geneesmiddel.
NL7503181A (nl) Werkwijze voor de bereiding van een geneesmiddel met maag-antisecretiewerking, een dergelijk ge- neesmiddel en een werkwijze voor de bereiding van de geneeskrachtige verbindingen.
NL7510155A (nl) Werkwijze voor de bereiding van n6-gesubstitu- eerde adenosinen, alsmede werkwijze voor de bereiding van een geneesmiddel onder toepassing van deze adenosinen.
NL7701509A (nl) Werkwijze voor de bereiding van verbindingen met anti-arrythmische werking, werkwijze voor de be- reiding van een geneesmiddel met anti-arrythmische werking en een dergelijke geneesmiddel.

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
A85 Still pending on 85-01-01
V1 Lapsed because of non-payment of the annual fee

Effective date: 19960601